Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

NCT06304636 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Phase 1 enrollment completed. Further clinical development terminated

Conditions

Refractory Multiple Myeloma
Relapsed Multiple Myeloma

Interventions

DRUG: Descartes-15

Sponsor

Cartesian Therapeutics